QuantRx, Fieldtests in DOA test manufacturing and distribution pact:
This article was originally published in Clinica
Executive Summary
Drugs-of-abuse (DOA) testing specialists QuantRx Biomedical and Fieldtests have entered a manufacturing and distribution agreement that will see QuantRx exclusively manufacture the Fieldtests ID product line. According to Doylestown, Pennsylvania-based QuantRx, the product line, which is designed to test for narcotic residue, will be available during the second quarter of 2008. The agreement will also see Fieldtests distribute QuantRx's QuikSense DOA products through its sales network. Fieldtests intends to extend the deal to cover QuantRx's RapidSense lateral flow test and OralSense oral fluid collection device when these products become commercially available. Financial details of the deal were not revealed.